Home
>
US Stocks
>
Corbus Pharmaceuticals Holdings Inc
Corbus Pharmaceuticals Holdings Inc
CRBP

Corbus Pharmaceuticals Holdings Inc (CRBP)

$0.9719.83%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
1.01
Today Low/High
0.97 / 1.01
52 Week Low/High
$0.91 / $9.78
P/E ratio
-2.008
Market Cap
$154.03M

Company Details

Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage company focused on the development and commercialization of novel medicines designed to target the endocannabinoid system. The Company's lead product candidate, lenabasum, is a novel, oral, selective cannabinoid receptor type 2 (CB2) agonist designed to provide an alternative to immunosuppressive medications in the treatment of chronic inflammatory and fibrotic diseases. Lenabasum is currently being evaluated in dermatomyositis and systemic lupus erythematosus. Corbus is also developing a pipeline of other preclinical drug candidates from its endocannabinoid system platform.
Organisation
Corbus Pharmaceuticals Holdings Inc
Headquaters
Norwood, Massachusetts, US
Employees
76
Industry
Health Technology
CEO
Yuval Cohen

Discover more

Frequently Asked Questions

What is Corbus Pharmaceuticals Holdings Inc (CRBP) share price today?

Can Indians buy Corbus Pharmaceuticals Holdings Inc (CRBP) shares?

How can I buy Corbus Pharmaceuticals Holdings Inc (CRBP) shares from India?

Can Fractional shares of Corbus Pharmaceuticals Holdings Inc (CRBP) be purchased?

What are the documents required to start investing in Corbus Pharmaceuticals Holdings Inc (CRBP) stocks?

We are a SEBI registered investement advisor